Lidocaine HCl

Phase 2Small molecule

MMayo Clinic

Lidocaine HCl is one of 62 small molecule programs targeting Neuropathic Pain. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Neuropathic PainActive, not recruiting

RadiculopathyActive, not recruiting

Neuropathic PainPhase 2

Active, not recruiting

RadiculopathyPreclinical

Active, not recruiting

Competition

Competitive Landscape

212 competitors in Neuropathic Pain

#DrugCompanyPhaseTrials

Elavil

AstraZeneca

Phase 3

4 2

Namenda

AbbVie

Phase 3

3 3

Xylocaine

MMEDRx USA, Inc.

Phase 3

9 4

Briviact

UCB

Phase 3

1 5

Sativex

Jazz Pharmaceuticals

Phase 3

6 6

Ultram

WWim Janssens

Phase 3

2 7

Ultiva

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Phase 3

2 8

Ketalar

Boehringer Ingelheim

Phase 3

2 9

Aspercreme Warming

AAveritas Pharma, Inc.

Phase 3

1 10

Paxil

SSebela Pharmaceuticals Development LLC

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Radiculopathy1 trial

Epidural Clonidine for Lumbosacral Radiculopathy

Terminated·MMayo Clinic·N/A·NCT00588354·26 enrolled

Bunion1 trial

Open-Label CA-008 (Vocacapsaicin) in Bunionectomy

Completed·CConcentric Analgesics·Phase 2·NCT03885596·36 enrolled

Pain Control1 trial

Lidocaine Jelly for Pain Control During Mohs Surgery

Completed·MMayo Clinic·Phase 4·NCT03595449·233 enrolled

Sore Throat1 trial

Effect of Betamethasone Gel and Lidocaine Jelly on Sore Throat, Cough and Hoarseness of

Completed·TTehran University of Medical Sciences·Phase 3·NCT02114021·99 enrolled

Neuropathic Pain1 trial

Efficacy and Safety of Lidocaine Infusion Treatment in Management of Neuropathic Pain

Unknown status·SSeoul National University Hospital·Phase 2·NCT02597257·44 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Lidocaine HCl. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Lidocaine HCl compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Lidocaine HCl. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Mayo Clinic company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: MMayo Clinic

Lidocaine HCl

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Radiculopathy1 trial

Bunion1 trial

Pain Control1 trial

Sore Throat1 trial

Neuropathic Pain1 trial

References

Drug Info

Quick Facts

Related News